InsiderTrades

Form 4 for BMY Bristol Myers Squibb

Accepted 2023-12-05 00:00:00 ET · period of report 2023-12-02 · accession 0000014272-23-000191 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-12-05 2023-12-02 BMY BOERNER CHRISTOPHER S. CEO F - Tax $50.10 -1,350 80.7K -2% -$67.6K
D 2023-12-05 2023-12-02 BMY BOERNER CHRISTOPHER S. CEO M - OptEx $0.00 +2,638 82.0K +3% $0
D 2023-12-05 2023-12-02 BMY BOERNER CHRISTOPHER S. CEO M - OptEx $0.00 -2,638 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock, $0.10 par value 2023-12-02 F D 1,350 $50.10 80,672 D — — (F2) Shares withheld for payment of taxes upon vesting of awards.
2 Common Common Stock, $0.10 par value 2023-12-02 M A 2,638 $0.00 82,022 D — — (F1) The restricted stock unit vests in four equal annual installments beginning on December 2, 2020.
3 Derivative Restricted Stock Units 2023-12-02 M D 2,638 $0.00 0 D — · — to 2023-12-02 2,638 Common Stock, $0.10 par value (F3) Each restricted stock unit converts into one share of common stock upon vesting. (F1) The restricted stock unit vests in four equal annual installments beginning on December 2, 2020.